86 related articles for article (PubMed ID: 14598568)
1. [Tenascin-C expression in human breast tumors].
Tökés AM; Kulka J
Orv Hetil; 2003 Sep; 144(39):1901-7. PubMed ID: 14598568
[TBL] [Abstract][Full Text] [Related]
2. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical localisation of tenascin in invasive ductal carcinoma of the breast.
Tökés AM; Hortoványi E; Csordás G; Kulka J; Mózes G; Hatalyák A; Kádár A
Anticancer Res; 1999; 19(1A):175-9. PubMed ID: 10226540
[TBL] [Abstract][Full Text] [Related]
4. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
5. Tenascin-A marker for the malignant potential of preinvasive breast cancers.
Goepel C; Buchmann J; Schultka R; Koelbl H
Gynecol Oncol; 2000 Dec; 79(3):372-8. PubMed ID: 11104607
[TBL] [Abstract][Full Text] [Related]
6. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
[TBL] [Abstract][Full Text] [Related]
7. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
8. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
9. Tenascin-W is found in malignant mammary tumors, promotes alpha8 integrin-dependent motility and requires p38MAPK activity for BMP-2 and TNF-alpha induced expression in vitro.
Scherberich A; Tucker RP; Degen M; Brown-Luedi M; Andres AC; Chiquet-Ehrismann R
Oncogene; 2005 Feb; 24(9):1525-32. PubMed ID: 15592496
[TBL] [Abstract][Full Text] [Related]
10. Towards defining roles and relationships for tenascin-C and TGFbeta-1 in the normal and neoplastic urinary bladder.
Booth C; Harnden P; Selby PJ; Southgate J
J Pathol; 2002 Nov; 198(3):359-68. PubMed ID: 12375269
[TBL] [Abstract][Full Text] [Related]
11. Expression of tenascin-c and CD44 receptors in cardiac myxomas.
Donato G; Conforti F; Zuccalà V; Russo E; Maltese L; Perrotta I; Amorosi A
Cardiovasc Pathol; 2009; 18(3):173-7. PubMed ID: 18502153
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the alpha v beta 6 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival.
Hazelbag S; Kenter GG; Gorter A; Dreef EJ; Koopman LA; Violette SM; Weinreb PH; Fleuren GJ
J Pathol; 2007 Jul; 212(3):316-24. PubMed ID: 17503414
[TBL] [Abstract][Full Text] [Related]
13. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S
Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317
[TBL] [Abstract][Full Text] [Related]
14. Expression of tenascin in tumors of the esophagus, small intestine and colorectum. An immunohistochemical study.
Broll R; Meyer S; Neuber M; Bruch HP
Gen Diagn Pathol; 1995 Oct; 141(2):111-9. PubMed ID: 8548591
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
16. Serum tenascin-C as a potential predictive marker of angiogenesis in non-small cell lung cancer.
Ishiwata T; Takahashi K; Shimanuki Y; Ohashi R; Cui R; Takahashi F; Shimizu K; Miura K; Fukuchi Y
Anticancer Res; 2005; 25(1B):489-95. PubMed ID: 15816617
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of tenascin-C expression in superficial and invasive bladder cancer.
Brunner A; Mayerl C; Tzankov A; Verdorfer I; Tschörner I; Rogatsch H; Mikuz G
J Clin Pathol; 2004 Sep; 57(9):927-31. PubMed ID: 15333651
[TBL] [Abstract][Full Text] [Related]
19. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
20. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma.
Katenkamp K; Berndt A; Hindermann W; Wunderlich H; Haas KM; Borsi L; Zardi L; Kosmehl H
J Pathol; 2004 Jul; 203(3):771-9. PubMed ID: 15221936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]